News | June 21, 2023
DGCI grants Emergency Use Authorisation to Gennova mRNA Covid booster vaccine
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
Subscribe To Our Newsletter & Stay Updated
